A review of caregiver costs included in cost-of-illness studies

被引:4
|
作者
Mattingly, T. Joseph, II [1 ,2 ]
Diaz Fernandez, Valeria [1 ]
Seo, Dominique [1 ]
Melgar Castillo, Andrea I. [1 ,2 ]
机构
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Pharm, PATIENTS Program, Baltimore, MD 21201 USA
关键词
Caregiver burden; cost-of-illness; indirect costs; societal perspective; INFORMAL-CARE; ECONOMIC VALUATION; PRODUCTIVITY COSTS; DEMENTIA PATIENTS; PALLIATIVE CARE; SOCIETAL COSTS; HEALTH-CARE; BURDEN; DISEASE; STROKE;
D O I
10.1080/14737167.2022.2080056
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction Economic evaluations typically focus solely on patient-specific costs with economic spillovers to informal caregivers less frequently evaluated. This may systematically underestimate the burden resulting from disease. Areas covered Cost-of-illness (COI) analyses that identified costs borne to caregiver(s) were identified using PubMed and Embase. We extracted study characteristics, clinical condition, costs, and cost methods. To compare caregiver costs reported across studies, estimated a single 'annual caregiver cost' amount in 2021 USD. Expert opinion A total of 51 studies met our search criteria for inclusion with estimates ranging from $30 - $86,543. The majority (63%, 32/51) of studies estimated caregiver time costs with fewer studies reporting productivity or other types of costs. Caregiver costs were frequently reported descriptively (69%, 35/51), with fewer studies reporting more rigorous methods of estimating costs. Only 27% (14/51) of studies included used an incremental analysis approach for caregiver costs. In a subgroup analysis of dementia-focused studies (n = 16), we found the average annual cost of caregiving time for patients with dementia was $30,562, ranging from $4,914 to $86,543. We identified a wide range in annual caregiver cost estimates, even when limiting by condition and cost type.
引用
收藏
页码:1051 / 1060
页数:10
相关论文
共 50 条
  • [31] Intersectoral costs of sexually transmitted infections (STIs) and HIV: a systematic review of cost-of-illness (COI) studies
    Schnitzler, Lena
    Jackson, Louise J.
    Paulus, Aggie T. G.
    Roberts, Tracy E.
    Evers, Silvia M. A. A.
    [J]. BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [32] A SYSTEMATIC REVIEW OF COST-OF-ILLNESS STUDIES IN CHRONIC HEART FAILURE
    Lesyuk, W.
    Kriza, C.
    Kolominsky-Rabas, P. L.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A484 - A484
  • [33] Cost-of-illness studies of inherited retinal diseases: a systematic review
    Qin Xiang Ng
    Clarence Ong
    Clyve Yu Leon Yaow
    Hwei Wuen Chan
    Julian Thumboo
    Yi Wang
    Gerald Choon Huat Koh
    [J]. Orphanet Journal of Rare Diseases, 19
  • [34] The scope of costs in alcohol studies: Cost-of-illness studies differ from economic evaluations
    van Gils P.F.
    Hamberg-van Reenen H.H.
    van den Berg M.
    Tariq L.
    de Wit G.A.
    [J]. Cost Effectiveness and Resource Allocation, 8 (1)
  • [35] The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review
    Juan Oliva-Moreno
    Marta Trapero-Bertran
    Luz Maria Peña-Longobardo
    Raúl del Pozo-Rubio
    [J]. PharmacoEconomics, 2017, 35 : 331 - 345
  • [36] Cost-of-Illness Studies in Systemic Lupus Erythematosus: A Systematic Review
    Zhu, Tracy Y.
    Tam, Lai Shan
    Li, Edmund K.
    [J]. ARTHRITIS CARE & RESEARCH, 2011, 63 (05) : 751 - 760
  • [37] COST-OF-ILLNESS STUDIES FOR JUVENILE IDIOPATHIC ARTHRITIS: A SYSTEMATIC REVIEW
    Hogan, M. E.
    Shah, V
    Katz, J.
    Krahn, M. D.
    Taddio, A.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A45 - A45
  • [38] The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review
    Oliva-Moreno, Juan
    Trapero-Bertran, Marta
    Maria Pena-Longobardo, Luz
    del Pozo-Rubio, Raul
    [J]. PHARMACOECONOMICS, 2017, 35 (03) : 331 - 345
  • [39] Cost-of-illness studies in diabetes mellitus
    Ettaro, L
    Songer, TJ
    Zhang, P
    Engelgau, MM
    [J]. PHARMACOECONOMICS, 2004, 22 (03) : 149 - 164
  • [40] Cost-of-Illness Studies in Diabetes Mellitus
    Lorraine Ettaro
    Thomas J. Songer
    Ping Zhang
    Michael M. Engelgau
    [J]. PharmacoEconomics, 2004, 22 : 149 - 164